Does OBINUTUZUMAB Cause Disease recurrence? 54 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Disease recurrence have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.4% of all adverse event reports for OBINUTUZUMAB.
54
Reports of Disease recurrence with OBINUTUZUMAB
0.4%
of all OBINUTUZUMAB reports
5
Deaths
3
Hospitalizations
How Dangerous Is Disease recurrence From OBINUTUZUMAB?
Of the 54 reports, 5 (9.3%) resulted in death, 3 (5.6%) required hospitalization.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 54 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which OBINUTUZUMAB Alternatives Have Lower Disease recurrence Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE